Magnus Bjursell
Magnus Bjursell
Associate principal scienctist, AstraZeneca R&D Mölndal, Sweden
Verified email at
Cited by
Cited by
A genomic view of the human-Bacteroides thetaiotaomicron symbiosis
J Xu, MK Bjursell, J Himrod, S Deng, LK Carmichael, HC Chiang, ...
Science 299 (5615), 2074-2076, 2003
Single-cell transcriptome profiling of human pancreatic islets in health and type 2 diabetes
Å Segerstolpe, A Palasantza, P Eliasson, EM Andersson, AC Andréasson, ...
Cell metabolism 24 (4), 593-607, 2016
Functional genomic and metabolic studies of the adaptations of a prominent adult human gut symbiont, Bacteroides thetaiotaomicron, to the suckling period
MK Bjursell, EC Martens, JI Gordon
Journal of biological chemistry 281 (47), 36269-36279, 2006
Message from a human gut symbiont: sensitivity is a prerequisite for sharing
J Xu, HC Chiang, MK Bjursell, JI Gordon
Trends in microbiology 12 (1), 21-28, 2004
Mutations in SLC12A5 in epilepsy of infancy with migrating focal seizures
T Stödberg, A McTague, AJ Ruiz, H Hirata, J Zhen, P Long, I Farabella, ...
Nature communications 6 (1), 8038, 2015
Adenosine kinase deficiency disrupts the methionine cycle and causes hypermethioninemia, encephalopathy, and abnormal liver function
MK Bjursell, HJ Blom, JA Cayuela, ML Engvall, N Lesko, ...
The American Journal of Human Genetics 89 (4), 507-515, 2011
Ligand binding mechanism in steroid receptors: from conserved plasticity to differential evolutionary constraints
K Edman, A Hosseini, MK Bjursell, A Aagaard, L Wissler, A Gunnarsson, ...
Structure 23 (12), 2280-2290, 2015
Genome sequencing reveals a phage in Helicobacter pylori
P Lehours, FF Vale, MK Bjursell, O Melefors, R Advani, S Glavas, ...
MBio 2 (6), 10.1128/mbio. 00239-11, 2011
Characterization of species-related differences in the pharmacology of tachykinin NK receptors 1, 2 and 3
A Leffler, I Ahlstedt, S Engberg, A Svensson, M Billger, L Öberg, ...
Biochemical pharmacology 77 (9), 1522-1530, 2009
In-depth transcriptome analysis reveals novel TARs and prevalent antisense transcription in human cell lines
D Klevebring, M Bjursell, O Emanuelsson, J Lundeberg
PLoS One 5 (3), e9762, 2010
Flow cytometry for enrichment and titration in massively parallel DNA sequencing
J Sandberg, PL Ståhl, A Ahmadian, MK Bjursell, J Lundeberg
Nucleic acids research 37 (8), e63-e63, 2009
Elevated uric acid prevalence and clinical outcomes in patients with heart failure with preserved ejection fraction: insights from RELAX
AP Carnicelli, JL Sun, B Alhanti, M Bjursell, S Perl, B Lytle, MT Roe, ...
The American journal of medicine 133 (12), e716-e721, 2020
Comparison of characteristics and outcomes of patients with heart failure with preserved ejection fraction with versus without hyperuricemia or gout
AP Carnicelli, R Clare, K Chiswell, B Lytle, M Bjursell, S Perl, ...
The American Journal of Cardiology 127, 64-72, 2020
Understanding the patient experience of chronic kidney disease stages 2–3b: a qualitative interview study with Kidney Disease Quality of Life (KDQOL-36) debrief
A Rydén, S Nolan, J Maher, O Meyers, A Kündig, M Bjursell
BMC nephrology 23 (1), 201, 2022
Mutations in SLC12A5 in epilepsy of infancy with migrating focal seizures. Nat Commun 6: 8038
T Stödberg, A McTague, AJ Ruiz, H Hirata, J Zhen, P Long, I Farabella, ...
Rationale, design, demographics and baseline characteristics of the randomized, controlled, Phase 2b SAPPHIRE study of verinurad plus allopurinol in patients with chronic …
HJL Heerspink, AG Stack, R Terkeltaub, TA Greene, LA Inker, M Bjursell, ...
Nephrology Dialysis Transplantation 37 (8), 1461-1471, 2022
Validation of whole genome amplification for analysis of the p53 tumor suppressor gene in limited amounts of tumor samples
J Hasmats, H Green, BW Solnestam, P Zajac, M Huss, C Orear, P Validire, ...
Biochemical and biophysical research communications 425 (2), 379-383, 2012
Translational database selection and multiplexed sequence capture for up front filtering of reliable breast cancer biomarker candidates
PL Ståhl, MK Bjursell, H Mahdessian, S Hober, K Jirström, J Lundeberg
Plos one 6 (6), e20794, 2011
Combination Treatment with Verinurad and Allopurinol in CKD: A Randomized Placebo and Active Controlled Trial
HJL Heerspink, AG Stack, R Terkeltaub, N Jongs, LA Inker, M Bjursell, ...
Journal of the American Society of Nephrology, 10.1681, 2024
Verinurad does not prolong QTc interval: a thorough QT study using concentration–QTc modelling
J Parkinson, C Dota, C Källgren, C Gottfridsson, M Bjursell, S Perl, ...
British Journal of Clinical Pharmacology 89 (6), 1747-1755, 2023
The system can't perform the operation now. Try again later.
Articles 1–20